The Pediatric Rehabilitation Medicine Fellowship at Children's Mercy Hospitals & Clinics is a two-year ACGME-accredited fellowship designed to develop advanced skills in the diagnosis and treatment of children with disabilities.
Fellows will have completed an approved residency training program in physical medicine and rehabilitation and may have additionally completed a pediatrics residency or a joint pediatrics/PM&R residency. The PRM curriculum is divided into block rotations of three months each. Educational programs are held in conjunction with the University of Kansas Medical Center Core Rehabilitation Medicine Program.
The clinical and didactic experiences are intended to expand the fellow’s knowledge of pediatric conditions resulting in disability including traumatic brain injury, spinal cord injury, Cerebral Palsy, neuromuscular disease, neural tube defects; amputations, and others in order to prepare them for a successful pediatric rehabilitation practice.
The fellow will gain clinic exposure and experience in various developmental, pediatric, and neuromuscular disorders, rehabilitations, and therapies.
1. Chemodenervation techniques- botulinum toxin injections and phenol injections with ultrasound and e-stim guidance 2. Pediatric EMG/NCS 3. Intrathecal Baclofen pump management 4. Intraoperative neurophysiologic monitoring 5. Pediatric trigger point injections
Director: Kimberly Hartman, MD
About Children's Mercy Hospital
Children’s Mercy Kansas City is an independent, non-profit, 367-bed pediatric health system, serving half a million patients each year from across the country. Children’s Mercy is ranked by U.S. News & World Report as one of “America’s Best Children’s Hospitals” and has received Magnet® recognition three times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City our faculty of nearly 750 pediatric subspecialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatric subspecialists. And, our leadership in pediatric genomic medicine and clinical pharmacology is driving research and innovation in heart care, neonatology, cancer treatment and other subspecialties to transform outcomes for children here and around the world.